BASS XXXII Tutorials and Keynote Address presentations:

SessionSpeakerPresentation
Keynote AddressDr. Stephan Ogenstad Trials and Tribulations: The Good, The Bad, and The Patently Absurd
M-1Dr. Daniel Backenroth Leveraging Baseline Covariate Adjustment Methods in
Oncology Time-to-Event Studies
M-2Dr. Fei Chen Driving Operational Excellence: The Power of Statistical Innovation in
Clinical Development
M-3Dr. Ekaterina Smirnova
 Bile Acids Are the Strong Indicators for the Progression of Metabolic
Dysfunction Associated Steatotic Liver Disease in Ethnically Diverse Populations
M-4Dr. George Kordzakhia Integrated Analysis of Pre-Marketing Safety Data,
Statistical Considerations and Estimands
T-1Dr. Benjamin Duncan Evaluating Frequentist and Bayesian Confidence Intervals for
Study Size Adjusted Risk Difference
T-2Dr. Melvin Munsaka Enhancing the DMC Data Package Using Open Source
Software, Artificial Intelligence, and Large Language Models
T-3Dr. Ryan Butterfield and Dr. Edward DeVol A Structured Approach to Designing Pivotal Diagnostic Accuracy
Studies for Noninvasive Tests Using Meta-Analytic Techniques
T-4Dr. Yevgen Tymofyeyev and Dr. Michael Grayling Multiple Testing in the Context of Group Sequential Designs
T-5Dr. Priyam Das SMART-MC: Characterizing the Dynamics of Multiple Sclerosis
Therapy Transitions Using a Covariate-Based Markov Model
T-6Dr. Stephan Ogenstad, Co-Authored by Greg Ginn Harnessing Simulation to Inform Endpoint Selection in
Cardiovascular Trials
W-1Dr. Emily Morris Rare Disease Clinical Trials: Challenges and Opportunities
W-2Dr. Weimeng Wang Collecting and Applying Evidence to Interpret Clinical Outcome
Assessments (COA)-based Endpoints in Clinical Trials